Wells Fargo & Company Boosts Alnylam Pharmaceuticals (NASDAQ:ALNY) Price Target to $207.00
Alnylam Pharmaceuticals (NASDAQ:ALNY – Free Report) had its price target lifted by Wells Fargo & Company from $161.00 to $207.00 in a research note released on Tuesday, Benzinga reports. They currently have an equal weight rating on the biopharmaceutical company’s stock. Several other research firms have also issued reports on ALNY. Chardan Capital reissued a […]
More Stories
GoalVest Advisory LLC Sells 3,237 Shares of Southern Copper Co. (NYSE:SCCO)
GoalVest Advisory LLC lowered its stake in shares of Southern Copper Co. (NYSE:SCCO – Free Report) by 16.4% during the...
Mutual of America Capital Management LLC Sells 7,761 Shares of Essent Group Ltd. (NYSE:ESNT)
Mutual of America Capital Management LLC lessened its holdings in Essent Group Ltd. (NYSE:ESNT – Free Report) by 3.4% during...
CIBC Asset Management Inc Buys 3,742 Shares of Coca-Cola Europacific Partners PLC (NASDAQ:CCEP)
CIBC Asset Management Inc lifted its stake in Coca-Cola Europacific Partners PLC (NASDAQ:CCEP – Free Report) by 3.8% during the...
Kovack Advisors Inc. Has $205,000 Stock Position in Alibaba Group Holding Limited (NYSE:BABA)
Kovack Advisors Inc. lessened its holdings in Alibaba Group Holding Limited (NYSE:BABA – Free Report) by 94.5% during the 3rd...
Schneider Downs Wealth Management Advisors LP Acquires Shares of 8,200 The Baldwin Insurance Group, Inc. (NASDAQ:BRP)
Schneider Downs Wealth Management Advisors LP purchased a new position in The Baldwin Insurance Group, Inc. (NASDAQ:BRP – Free Report)...
Vaughan Nelson Investment Management L.P. Purchases 152,030 Shares of Beacon Roofing Supply, Inc. (NASDAQ:BECN)
Vaughan Nelson Investment Management L.P. raised its holdings in Beacon Roofing Supply, Inc. (NASDAQ:BECN – Free Report) by 18.7% during...